EVERSANA is a proud sponsor of the 2021 NORD Rare Diseases & Orphan Products Breakthrough Summit and advance the dialogue on ways to improve the lives of over 25 million Americans living with rare diseases.
The NORD Summit is one of largest multi-stakeholder events in the rare disease community. The two-day summit brings together members of the rare disease community from across the globe, including rare disease experts and leaders from patient advocacy groups, government, industry, and academia to share new insights, network in a positive and practical virtual environment, and discuss critical topics in the rare diseases and orphan products field.
All general sessions and breakout sessions will be recorded so that you may watch them at your convenience. Content will be available for 30 days after the conference. Networking sessions will only be available live.
Solving Industry Challenges With the Only End-to-End Commercialization Solution
In a competitive global market, pharmaceutical manufacturers can’t afford to waste time or resources on inefficient commercialization strategies.
EVERSANA™ COMPLETE Commercialization is an award winning model that is disrupting the pharma industry by optimizing investments, minimizing risk and increasing speed to market.
This innovative model:
- Delivers more value than traditional licensing or launching on your own.
- Activates a complete, ready-to-deploy, high-performance commercialization and distribution engine.
- Accelerates your product from early development to marketing, effectively impacting patient outcomes and beyond.
Ready to learn more about EVERSANA? Connect with one our experts today.